IP Library › Granted Patent US 6,956,108
Granted Patent B2
US 6,956,108 · App. 09/992,598 · Granted Oct 18, 2005

PRO1184 antibodies

Assignee: Genentech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,956,108
App. No.
09/992,598
Granted
Oct 18, 2005
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (4)

1. An isolated antibody that specifically binds to the polypeptide of SEQ ID NO:270.

2. The antibody of claim 1 which is a monoclonal antibody.

3. The antibody of claim 1 which is a humanized antibody.

4. The antibody of claim 1 which is labeled.

Continuity (7)
Continuation 0994199200 · Aug 28, 2001
Continuation PCTUS000843900 · Mar 30, 2000
Continuation In Part PCTUS000584100 · Mar 2, 2000
Continuation In Part 0938013700
Provisional Application 6014103700 · Jun 23, 1999
Provisional Application 6008874100 · Jun 10, 1998
Related Publication 20020160384A1 · Oct 31, 2002